References
Moon RC, Thompson HJ, Becci PJ, Grubbs CJ, Gander RJ, Newton DL, Smith JM, Phillips SL, Henderson WR, Mullen LT, Brown CC, Sporn MB: N-(4-hydroxyphenyl)-retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res 39: 1339–1346, 1979
McCormick DL, Metha RG, Thompson CA, Dinger N, Caldwell JA, Moon RC: Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)-retinamide and ovariectomy. Cancer Res 42: 508–512, 1982
McCormick DL, Moon RC: Retinoid-tamoxifen interaction in mammary cancer chemoprevention. Carcinogenesis 7: 193–196, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Secreto, G., Costa, A., Recchione, C. et al. The synthetic retinoid Fenretinide does not affect circulating hormone concentrations. Breast Cancer Res Tr 12, 315–316 (1988). https://doi.org/10.1007/BF01811246
Issue Date:
DOI: https://doi.org/10.1007/BF01811246